Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Abercrombie & Fitch
ANF
$4.86B
| $9.47M | ﹤0.01% |
890,568
+11,429
| +1% | +$125K |
|
1952
Invesco Mortgage Capital
IVR
$761M
| $9.46M | ﹤0.01% |
252,941
+33,148
| +15% | +$1.14M |
|
1953
Vericel Corp
VCEL
$2.32B
| $9.42M | ﹤0.01% |
681,753
+17,646
| +3% | +$239K |
|
1954
CTS Corp
CTS
$1.91B
| $9.39M | ﹤0.01% |
468,835
+6,933
| +2% | +$149K |
|
|
EBSB
1955
DELISTED
Meridian Bancorp, Inc.
EBSB
| $9.38M | ﹤0.01% |
809,160
+23,713
| +3% | +$263K |
|
1956
Brookfield Infrastructure
BIPC
$4.94B
| $9.37M | ﹤0.01% |
+308,486
| New | +$8.96M |
|
|
RDUS
1957
DELISTED
Radius Health, Inc.
RDUS
| $9.34M | ﹤0.01% |
685,539
+11,763
| +2% | +$162K |
|
1958
ADT
ADT
$5.63B
| $9.32M | ﹤0.01% |
1,167,832
-10,437
| -0.9% | -$67.5K |
|
1959
Argan
AGX
$8.44B
| $9.3M | ﹤0.01% |
196,359
-750
| -0.4% | -$28.7K |
|
|
OSG
1960
Octave Specialty Group
OSG
$256M
| $9.3M | ﹤0.01% |
649,521
+180
| +0% | +$2.63K |
|
1961
Cue Biopharma
CUE
$112M
| $9.25M | ﹤0.01% |
12,575
+2,289
| +22% | +$1.66M |
|
1962
Vanda Pharmaceuticals
VNDA
$306M
| $9.22M | ﹤0.01% |
805,918
+43,693
| +6% | +$495K |
|
1963
Teck Resources
TECK
$32.4B
| $9.2M | ﹤0.01% |
862,436
+46,588
| +6% | +$428K |
|
1964
United Fire Group
UFCS
$1.4B
| $9.19M | ﹤0.01% |
331,636
+4,867
| +1% | +$137K |
|
1965
Pathward Financial
CASH
$1.88B
| $9.17M | ﹤0.01% |
504,952
-6,681
| -1% | -$117K |
|
1966
Apogee Enterprises
APOG
$897M
| $9.16M | ﹤0.01% |
397,549
+7,934
| +2% | +$162K |
|
1967
Dave & Buster's
PLAY
$364M
| $9.16M | ﹤0.01% |
686,905
+234,302
| +52% | +$3.12M |
|
|
KBAL
1968
DELISTED
Kimball International
KBAL
| $9.13M | ﹤0.01% |
789,942
+20,480
| +3% | +$234K |
|
1969
GoPro
GPRO
$125M
| $9.08M | ﹤0.01% |
1,908,054
+45,627
| +2% | +$173K |
|
1970
Pennant Group
PNTG
$1.35B
| $9.05M | ﹤0.01% |
400,566
+14,462
| +4% | +$303K |
|
|
AERI
1971
DELISTED
Aerie Pharmaceuticals
AERI
| $9.03M | ﹤0.01% |
611,772
-25,142
| -4% | -$372K |
|
1972
Anterix
ATEX
$1.94B
| $9.03M | ﹤0.01% |
199,111
+8,495
| +4% | +$434K |
|
|
LBAI
1973
DELISTED
Lakeland Bancorp Inc
LBAI
| $9.03M | ﹤0.01% |
789,815
+20,684
| +3% | +$223K |
|
1974
Oceaneering
OII
$4.78B
| $8.99M | ﹤0.01% |
1,406,854
+35,692
| +3% | +$188K |
|
1975
St. Joe Company
JOE
$3.7B
| $8.99M | ﹤0.01% |
462,723
-754
| -0.2% | -$13.9K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.